CN110876691A - Coenzyme Q10Sleep-aiding skin-beautifying massage emulsion - Google Patents

Coenzyme Q10Sleep-aiding skin-beautifying massage emulsion Download PDF

Info

Publication number
CN110876691A
CN110876691A CN201911038985.6A CN201911038985A CN110876691A CN 110876691 A CN110876691 A CN 110876691A CN 201911038985 A CN201911038985 A CN 201911038985A CN 110876691 A CN110876691 A CN 110876691A
Authority
CN
China
Prior art keywords
coenzyme
melatonin
preparation
massage
sleep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911038985.6A
Other languages
Chinese (zh)
Inventor
吴铁
唐林志
于琼
吕思敏
丁鸿燕
丁喜生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUANGDONG RUNHE BIOTECHNOLOGY Co Ltd
Guangdong Medical University
Original Assignee
GUANGDONG RUNHE BIOTECHNOLOGY Co Ltd
Guangdong Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUANGDONG RUNHE BIOTECHNOLOGY Co Ltd, Guangdong Medical University filed Critical GUANGDONG RUNHE BIOTECHNOLOGY Co Ltd
Priority to CN201911038985.6A priority Critical patent/CN110876691A/en
Publication of CN110876691A publication Critical patent/CN110876691A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • A61K8/355Quinones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses coenzyme Q10And melatonin in preparing external massage preparation for improving sleep and caring skin. The research finds that the coenzyme Q10The melatonin is added into massage cream, massage cream and massage oil according to a certain proportion, so that the skin-beautifying effect and the sleep-aiding effect are achieved, and the addition amount of the two is every 100 g of cream or every 100 g of creamCoenzyme Q in 100 ml of oil solution10And melatonin are preferably added in an amount of 0.1 to 5.0g, with the optimal ratio of the two being 1: 6. The invention also discloses the formulation and preparation process of 5 external preparations of massage cream, massage cream and massage oil containing the two components. When the external massage preparation is applied, a small amount of the external massage preparation is smeared on the skin, and then the skin is slightly massaged or is massaged in cooperation with acupuncture points, so that the sleep can be quickly induced, the sleep time is shortened, the sleep quality is improved, and the external massage preparation has good skin moistening, repairing and whitening effects on the skin. Animal experiment results also prove that the external massage preparation has the function of helping sleep.

Description

Coenzyme Q10Sleep-aiding skin-beautifying massage emulsion
Technical Field
The invention relates to a group of coenzyme Q10The external massage preparation with the functions of helping sleep and beautifying skin comprises massage milk, massage cream and massage oil, and has better sleep-helping function for people with mild sleep disorder and insomnia. When the skin care product is applied, a small amount of the skin care product is smeared on the skin, and then the skin care product is slightly massaged or matched with acupuncture point massage, so that the sleep can be quickly induced, the sleep time is shortened, the sleep quality is improved, and the skin care product has good skin moistening, repairing and whitening effects on the skin, and belongs to the technical field of external pharmaceutical preparations and skin care products.
Background
Insomnia is common in daily life, and almost every adult experiences insomnia, and the common manifestations are difficulty in falling asleep, sleep quality reduction, sleep time reduction, memory and attention reduction, and the like. Modern medicine has limitations on the understanding of insomnia, but clinical physicians have begun to define insomnia according to clinical studies, and the neurological society sleep disorder group of the Chinese medical society in 2012 made "Chinese adult insomnia diagnosis and treatment guidelines" according to the existing evidence of evidence, wherein insomnia refers to a subjective experience of a patient that the sleep time and/or quality are not satisfied and the daily social function is affected. Insomnia can be classified into primary and secondary types according to its etiology. (1) Primary insomnia: mainly comprises 3 types of psychophysiological insomnia, idiopathic insomnia and subjective insomnia. The primary insomnia usually lacks a definite cause or still remains insomnia symptoms after eliminating causes which may cause insomnia, and the diagnosis lacks a specific index, which is mainly an exclusive diagnosis. Primary insomnia is considered to be caused when insomnia symptoms remain after the etiology that may cause insomnia is eliminated or cured. According to the psychological and physiological insomnia, the etiology can be traced to the influence of a certain or long-term event on the functional stability of the peripheral system of the brain of a patient, and the imbalance of the functional stability of the peripheral system finally causes the disorder of the brain sleep function and the insomnia. (2) Secondary insomnia: including insomnia due to physical diseases, mental disorders, drug abuse, etc., and insomnia associated with sleep disordered breathing, sleep movement disorders, etc. Insomnia frequently occurs simultaneously with other diseases, and sometimes it is difficult to determine the causal relationship between these diseases and insomnia, so in recent years the concept of comorbidinsomnia has been proposed to describe those insomnia that are accompanied simultaneously with other diseases.
Methods of treatment for insomnia include drug therapy and non-drug therapy. The clinical medicine mainly takes drug therapy as the main part, and the drugs for clinically treating insomnia at present mainly comprise benzodiazepine receptor agonists, melatonin receptor agonists and antidepressant drugs with hypnotic effect. Although antihistamine (such as diphenhydramine), melatonin and valerian extract have hypnotic effect, the existing clinical research evidence is limited, and the extract is not suitable for conventional insomnia medication. The drugs for treating insomnia are complex and numerous and include estazolam, flurazepam, quazepam, temazepam, triazolam, alprazolam, chlordiazepoxide, diazepam, lorazepam, midazolam, zolpidem controlled release agents, zopiclone, eszopiclone and zaleplon, ramelten, agomelatine, tricyclic antidepressants, selective 5-tryptamine reuptake inhibitors (SSRIs), 5-hydroxytryptamine and noradrenaline reuptake inhibitors (SNRIs), small doses of mirtazapine, small doses of trazodone, and the like. Because of the possibility of some drugs being dependent, long-term administration is generally not advocated.
Melatonin is a hormone substance capable of lightening skin pigment, which is synthesized by mammals and humans in pineal gland with tryptophan as matrix and has chemical name of N-acetyl, 5-methoxytryptamine. The physiological effects includeRegulating biological clock, inducing sleep, regulating endocrine system, delaying aging, and enhancing immunity, is called "Physiological catalysis Sleep improving agent". The exogenous administration of melatonin can shorten the wake-up time before sleep and the sleep-in time, improve the sleep quality, obviously reduce the wake-up times in sleep, shorten the light sleep stage, prolong the deep sleep stage and reduce the wake-up threshold in the next morning. Has stronger function of adjusting time difference. The biological functions of melatonin, especially the health care function as a dietary supplement, are widely researched at home and abroad, and the melatonin has multiple physiological functions of promoting sleep, regulating jet lag, resisting aging, regulating immunity, resisting tumors and the like. The health care function of melatonin at home and abroad relates to the regulation of endocrine (ovulation inhibition), the protection of encephalitis virus infection, the reduction of death rate after infection, the treatment of AIDS, the protection of cardiovascular and the like. The oral melatonin is proved to improve the sleep quality and have the treatment effect on insomnia, particularly can regulate the rhythm of sleep, has no phenomena of dizziness and somnolence on the next day, and has no obvious side effect even if being taken in large dose for a long time. Because the half-life period of melatonin is too short and the blood concentration fluctuation is large, although the melatonin can effectively induce sleep before taking, the effect on prolonging the sleep time is unstable, so the melatonin is mainly clinically used for treating sleep disorder in the form of a health-care product at present, and meanwhile, the sustained-release preparation is actively developed. Melatonin can resist melanin in skin, so that the melatonin is approved to be used in skin care products for whitening and moisturizing, and researches show that the melatonin has good bioavailability when being applied through skin, and the medicament can generate good sustained and controlled release effects when being applied through skin and can solve the problem of short half-life period of the melatonin. Our research finds that melatonin can be absorbed through skin, and when the melatonin is externally applied to reach a certain amount, a sleep-aiding effect can also occur. The sleep-aiding massage cream with various concentrations is prepared, an in-vitro transdermal experiment is carried out on the skin of a mouse, and an overall transdermal experiment research of a depilated mouse is also carried out, so that the melatonin can play a transdermal role only under a relatively large dosage. When the dosage is converted into cream, the cream can play a good sleep-aiding role until more than 3-5 g of the cream is contained in every 100 g of the cream. Further research shows that melatonin is mixed with coenzyme Q10The combined application can also exert better sleep-aiding effect even if a small dosage of melatonin is applied.
Coenzyme Q10Is a coenzyme, coenzyme Q, which can be synthesized and updated by human body10Coenzyme Q has been widely used in clinic as a fat-soluble antioxidant10Can activate human cells and nutrition of cell energy, has the functions of improving human immunity, enhancing oxidation resistance, delaying senility, enhancing human vitality and the like, is proved in the aspects of prevention and treatment of diseases such as cardiovascular system and the like, and is widely used as a nutritional health product and a food additive at home and abroad. Coenzyme Q10The beneficial effects on the skin have also been confirmed, with the skin collagen having a reduced ability to withstand damage from oxidative stimuli such as ultraviolet light with age, and coenzyme Q has been used for a long period of time10Can effectively prevent skin photoaging and reduce wrinkles around eyes due to coenzyme Q10The skin growth layer can weaken the oxidation reaction of photons, can start specific phosphorylated tyrosine kinase with the help of tocopherol, prevent the oxidative damage of DNA, inhibit the expression of human skin fibroblast collagenase under the irradiation of ultraviolet light, and protect the skin from being damaged. Extensive research suggests that coenzyme Q10Inhibiting lipid peroxidation, reducing free radical generation, protecting SOD active center and its structure from free radical oxidation damage, improving in vivo SOD enzyme activity, inhibiting oxidative stress induced apoptosis, and resisting oxidation and delaying aging. Our observations of prolonged administration of coenzyme Q10The people have better sleep and have less insomnia, which is combined with coenzyme Q10In connection with a beneficial effect on the human nervous system, we have also observed that coenzyme Q10When taken together with melatonin, the medicine has better sleep effect and certain curative effect on general insomnia. Further, we found that coenzyme Q10The melatonin and the melatonin are combined to form a massage cream, people with poor sleep are massaged before sleeping, the massage cream also has a good sleep promoting effect, the two components are subjected to composition research through animal experiments, and the best massage cream is found through combination of the two components in different proportionsThe best coenzyme Q group is finally found10The invention discloses a formula and a production process of melatonin massage cream, and accordingly, the invention is reported.
Disclosure of Invention
Our research found that coenzyme Q10Coenzyme Q, a beneficial effect on the human sleep-related nervous system10When taken together with melatonin, the medicine has better sleep effect and certain curative effect on insomnia. Further research finds that the coenzyme Q10The melatonin is added into the externally applied massage cream together, people with poor sleep are massaged before sleeping, and the massage cream also has a good sleep promoting effect, so that the invention provides a group of coenzyme Q10And melatonin, and can be used as massage cream for skin care and sleep, including cream, emulsion and oil. Adding coenzyme Q into the base of externally applied ointment, cream, emulsion and oil preparation prepared conventionally10And melatonin are prepared into various preparations for clinical external use, and the preparations can be prepared into products with the effect of inducing sleep. The formulation is characterized by containing coenzyme Q10Melatonin component in 100 ml cream or 100 ml oil solution and coenzyme Q10The content of (A) is 0.1-5.0 g, the content of melatonin is 1.0-5.0 g, and the optimal ratio of the two is 1: 6.
The specific implementation mode is as follows:
the following are specific embodiments of the present invention and further description of the technical solutions of the present invention, but the scope of the present invention is not limited to these embodiments, and all changes or equivalent substitutions that do not depart from the spirit of the present invention are included in the scope of the present invention.
Example one
Coenzyme Q10The formula of the sleep-aiding milk comprises (100 g): coenzyme Q100.1 to 5.0g, melatonin 1.0 to 5.0g, tyrosine 1.0 to 5.0g, dipotassium glycyrrhizinate 0.1 to 1.0 g, menthol 0.1 to 1.0 g, almond oil 10 to 20g, vitamin B60.1 to 1.0 g, glycerin 2.0 to 5.0g, azone 0.5 to E3.0g of lavender essential oil, 0.1-1.0 g of lavender essential oil, 5.0-10 g of emulsifier, 1.0-5.0 g of ethanol, and the balance of distilled water to make up to 100 g.
Dissolving melatonin with glycerol, adding ethanol, Mentholum, azone, and lavender essential oil, and mixing to obtain liquid A; dissolving tyrosine, dipotassium glycyrrhizinate, vitamin B6 and phenoxyethanol in distilled water to obtain a liquid B; fully and uniformly mixing the liquid A and the liquid B to obtain liquid C; adding coenzyme Q10Mixing with oleum Armeniacae amarum emulsifier, heating to dissolve to obtain liquid D; and fully and uniformly mixing the liquid C and the liquid D, emulsifying and uniformly mixing to obtain a finished product.
Coenzyme Q10The optimal formula proportion of the sleep-aiding milk is as follows: coenzyme Q100.5 g, 3.0g of melatonin, 3.0g of tyrosine, 0.3 g of dipotassium glycyrrhizinate, 0.5 g of menthol, 17 g of almond oil, 60.3 g of vitamin B and 10g of glycerol; 3.0g of azone, 0.5 g of lavender essential oil, 8.0 g of emulsifier, 2.0 g of ethanol and the balance of distilled water to make up to 100 g.
Example two
Coenzyme Q10The formula of the sleep-aiding cream comprises (100 g): coenzyme Q100.1-5.0 g of melatonin, 1.0-5.0 g of white oil, 20-25 g of white oil, 8.0-12.0 g of beeswax, 20-25 g of isopropyl myristate, 0.1-0.2 g of borax, 5-10 g of liquid paraffin, 2.0-3.0 g of P0E (25) sorbitan monoester, 12-15 g of vaseline, 2.0-3.0 g of glyceryl monostearate, 60.1-1.0 g of vitamin B, 1.0-5.0 g of tyrosine, 0.1-1.0 g of dipotassium glycyrrhizinate and 2-3 g of glycerol; 2-3 g of propylene glycol; 0.5-1 g of azone, a proper amount of essence and the balance of distilled water, wherein the balance is up to 100 g.
The preparation method comprises the following steps: taking coenzyme Q10Adding melatonin into the oil phase component, mixing and heating to 75 deg.C; mixing dipotassium glycyrrhizinate, tyrosine and water phase components, and heating to 75 deg.C; slowly adding the oil phase component into the water phase component, emulsifying, cooling to 40 deg.C, adding vitamin B6 and essence, and stirring to obtain the final product.
EXAMPLE III
Coenzyme Q10The formula of the sleep-aiding paste comprises (100 g): coenzyme Q100.1-5.0 g, fading black1.0-5.0 g of vitamin, 1.0-5.0 g of tyrosine, 0.1-1.0 g of dipotassium glycyrrhizinate, 60.1-1.0 g of vitamin B, 0.01-0.05 g of lipoic acid and 6-10 g of liquid paraffin; 2-4 g of polyoxyethylene (2) stearyl alcohol ether; 2-4 g of isopropyl myristate; 1-3 g of lanolin; 1-3 g of vaseline; 1-3 g of monoglyceride; 1-3 g of hexadecanol; 1-3 g of almond oil; 0.02-0.1 g of candelilla wax; 0.1-0.1 g of ethylparaben, 3-4 g of polyoxyethylene (21) stearyl ether; 2-3 g of glycerol; 2-3 g of propylene glycol; 0.5-1 g of azone; proper amount of essence and the balance of distilled water are added to make up to 100 g.
The preparation method comprises the following steps: taking coenzyme Q10Adding melatonin into the oil phase component, mixing and heating to 75 deg.C; mixing dipotassium glycyrrhizinate, tyrosine and lipoic acid with water phase components, and heating to 75 deg.C; slowly adding the oil phase component into the water phase component, emulsifying, cooling to 40 deg.C, adding vitamin B6 and essence, and stirring to obtain the final product.
Example four
Coenzyme Q10The formula of the sleep-aiding massage oil (I) comprises the following components (100 ml): coenzyme Q100.1-8.0 g of melatonin, 1.0-5.0 g of tyrosine, 0.1-1.0 g of dipotassium glycyrrhizinate, 60.1-1.0 g of vitamin B, 0.01-0.05 g of lipoic acid, 30-35 g of almond oil, 40-50 g of liquid paraffin and 2-3 g of glycerol; 2-3 g of propylene glycol; 0.5-1 g of azone and a proper amount of essence.
The preparation method comprises the following steps: slowly heating all the materials except essence under stirring until all the materials are dissolved, and adding essence when the temperature of the materials is reduced to 45 ℃.
EXAMPLE five
Coenzyme Q10The formula of the sleep-aiding skin-beautifying massage oil (II) comprises the following components (100 milliliters): coenzyme Q100.1-8.0 g of melatonin, 1.0-5.0 g of tyrosine, 0.1-1.0 g of dipotassium glycyrrhizinate, 60.1-1.0 g of vitamin B, 0.01-0.05 g of lipoic acid, 40-45 g of isopropyl myristate, 40-45 g of caprylic/capric triglyceride, 8-10 g of silicone oil and 2-3 g of glycerol; 2-3 g of propylene glycol; 0.5-1 g of azone and a proper amount of essence.
The preparation method comprises the following steps: slowly heating all the materials except essence under stirring until all the materials are dissolved, and adding essence when the temperature of the materials is reduced to 45 ℃.
Evaluation of animal experiments
To observe coenzyme Q10The curative effect of the sleep-aiding milk is that animal experiments are carried out on products prepared by the formulas according to the pharmacodynamic evaluation method, and preliminary research results are obtained, which are briefly described as follows.
Experiment 1 coenzyme Q10Observation of the sleep-aid milk on the autonomous movement of the mouse: taking 18-20 g of normal mice, removing hair from the center of the back of the mice, randomly dividing into 3 groups, each group containing 10 mice, and the 1 st group as sleep-promoting emulsion blank control group, i.e. the emulsion does not contain coenzyme Q10And melatonin, the other components are the same, group 2 is melatonin milk-aid group, and the group does not contain coenzyme Q10. Group 3 is coenzyme Q10And melatonin sleep-aid milk group, namely the formula group of the first embodiment; in the experiment, 30 drops of corresponding emulsion are smeared on the dead center of the back of each group of mice according to groups, and the mice are massaged and absorbed within 5 minutes. After the massage is finished, the mouse is placed into an observation cage, the subsequent mouse activity condition within 65 minutes is recorded, the exercise frequency of each mouse within 50-60 minutes is counted (the two forelimbs of the mouse are counted off the ground simultaneously), and the result shows that the group 3 contains coenzyme Q (shown in table 1)10The composition has obvious inhibition effect on the autonomous movement of mice with the melatonin milk-aid group, and the group 2 only contains the melatonin milk-aid group also has a certain reduction effect, but the effect is not obvious.
TABLE 1 coenzyme Q10Observations of the sleep-aid milk on the voluntary movements of the mice are as follows.
Figure 547512DEST_PATH_IMAGE001
Experiment 2 coenzyme Q10Observation of sleep-aid milk on mouse suprathreshold pentobarbital sodium sleep test: taking 18-20 g of normal mice, feeding for two weeks, fasting for 8 hours at 7 am during experiment, randomly dividing the mice into 3 groups, each group containing 10 mice, using the same medicine as experiment 1, and taking group 1 as sleep-aid milkBlank control group, group 2 is melatonin milk for improving sleep, and the group does not contain coenzyme Q10. Group 3 is coenzyme Q10And melatonin sleep-promoting milk group; the experiment was started by slowly dropping 15 drops of cream on the skin depilated on the back and massaging for absorption within 3 min. 50min after smearing administration, each group of mice is 45 mg/kg-1Pentobarbital sodium (0.1 mL/10g by weight) is intraperitoneally injected with BW dosage, the injection time (T.R) is recorded, when the inversion positive reflex disappears for 1min within 15min, the recording time indicates that the mouse falls asleep (T.S), when the inversion positive reflex recovers, the recording time indicates that the mouse sleeps and wakes up (T.W). The ① sleep latency (T.S-T.R), the time indicating that the mouse disappears from the administration to the inversion positive reflex, the ② sleep duration (T.W-T.S), the time indicating that the mouse disappears from the inversion positive reflex to the inversion positive reflex recovery are respectively calculated according to the indexes, the experimental results can be seen (see table 2), the 3 rd group contains coenzyme Q10The sleep-aid milk with the melatonin can effectively prolong the sleep time of the pentobarbital and shorten the latency time, and the effect of independently applying the melatonin is not obvious.
TABLE 2 coenzyme Q10The observation of the sleep-aid milk on the mouse suprathreshold sodium pentobarbital sleep test is as follows.
Figure 402336DEST_PATH_IMAGE002
Note: p <0.05 compared to the first group; p <0.01 compared to the first group.
Volunteer evaluations were as follows.
Case 1: li in Li, 57 years old, is difficult to fall asleep, easy to wake up after sleeping, and difficult to fall asleep again after waking up. The product is applied to the skin of ears, forehead, etc., to make the skin feel cool and comfortable, make it easy to fall asleep, prolong sleep time, improve wakefulness, and keep good in state the next day.
Case 2: in 37 years old, sleep is usually adequate at ordinary times, but after 1 o' clock, the mouth is dry and bitter, and it is difficult to fall asleep. The product is applied to the skin of the back of the ear, forehead and nape, and the skin is cool and comfortable, people feel relaxed, the mouth is dry, the tongue is bitter, the product can be improved, the product can sleep in about 20min, and no phenomena of dizziness, difficulty in sleeping and the like exist in the next day.
Case 3: qiu Zhi, 65 years old, insomnia, poor sensation and dreaminess, a proper amount of the product is taken and smeared on the skin, the acupuncture points are slightly massaged, and the user can sleep and sense at night basically.

Claims (8)

1. Coenzyme Q10The application of the melatonin composition in preparing an external massage preparation with the functions of helping sleep and beautifying skin.
2. The coenzyme Q according to claim 110The application of the melatonin composition in preparing an external massage preparation with the functions of helping sleep and beautifying skin is characterized in that the preparation is massage cream, massage cream and massage oil.
3. The coenzyme Q according to claim 110The application of the melatonin composition in preparing an external massage preparation with the functions of helping sleep and beautifying skin is characterized in that the preparation method of the massage emulsion comprises the following steps:
(1) the raw materials comprise: coenzyme Q100.1-5.0 g of melatonin, 1.0-5.0 g of tyrosine, 1.0-5.0 g of dipotassium glycyrrhizinate, 0.1-1.0 g of menthol, 10-20 g of almond oil, 60.1-1.0 g of vitamin B, 2.0-5.0 g of glycerol, 0.5-3.0 g of azone, 0.1-1.0 g of lavender essential oil, 5.0-10 g of emulsifier, 1.0-5.0 g of ethanol, and the balance of distilled water which is supplemented to 100 g;
(2) the preparation method comprises the following steps: dissolving melatonin with glycerol, adding ethanol, Mentholum, azone, and lavender essential oil, and mixing to obtain liquid A; dissolving tyrosine, dipotassium glycyrrhizinate, vitamin B6 and phenoxyethanol in distilled water to obtain a liquid B; fully and uniformly mixing the liquid A and the liquid B to obtain liquid C; then mixing coenzyme Q10 and almond oil emulsifier, heating and dissolving to obtain liquid D; and fully and uniformly mixing the liquid C and the liquid D, emulsifying and uniformly mixing to obtain a finished product.
4. The coenzyme Q according to claim 110The application of the composition and the melatonin in preparing the external massage preparation with the functions of helping sleep and beautifying skin is characterized in that the massage creamThe preparation method comprises the following steps:
(1) the raw materials comprise: coenzyme Q100.1-5.0 g of melatonin, 1.0-5.0 g of white oil, 20-25 g of white oil, 8.0-12.0 g of beeswax, 20-25 g of isopropyl myristate, 0.1-0.2 g of borax, 5-10 g of liquid paraffin, 2.0-3.0 g of P0E (25) sorbitan monoester, 12-15 g of vaseline, 2.0-3.0 g of glyceryl monostearate, 60.1-1.0 g of vitamin B, 1.0-5.0 g of tyrosine, 0.1-1.0 g of dipotassium glycyrrhizinate and 2-3 g of glycerol; 2-3 g of propylene glycol; 0.5-1 g of azone, a proper amount of essence and the balance of distilled water, wherein the balance is the balance, and the weight is 100 g;
(2) the preparation method comprises the following steps: taking coenzyme Q10Adding melatonin into the oil phase component, mixing and heating to 75 deg.C; mixing dipotassium glycyrrhizinate, tyrosine and water phase components, and heating to 75 deg.C; slowly adding the oil phase component into the water phase component, emulsifying, cooling to 40 deg.C, adding vitamin B6 and essence, and stirring to obtain the final product.
5. The coenzyme Q according to claim 110The application of the melatonin composition in preparing an external massage preparation with the functions of helping sleep and beautifying skin is characterized in that the preparation method of the massage cream is as follows:
(1) the raw materials comprise: coenzyme Q100.1-5.0 g of melatonin, 1.0-5.0 g of tyrosine, 0.1-1.0 g of dipotassium glycyrrhizinate, 60.1-1.0 g of vitamin B, 0.01-0.05 g of lipoic acid and 6-10 g of liquid paraffin; 2-4 g of polyoxyethylene (2) stearyl alcohol ether; 2-4 g of isopropyl myristate; 1-3 g of lanolin; 1-3 g of vaseline; 1-3 g of monoglyceride; 1-3 g of hexadecanol; 1-3 g of almond oil; 0.02-0.1 g of candelilla wax; 0.1-0.1 g of ethylparaben, 3-4 g of polyoxyethylene (21) stearyl ether; 2-3 g of glycerol; 2-3 g of propylene glycol; 0.5-1 g of azone; proper amount of essence, and the balance of distilled water to 100 g;
(2) the preparation method comprises the following steps: taking coenzyme Q10Adding melatonin into the oil phase component, mixing and heating to 75 deg.C; mixing dipotassium glycyrrhizinate, tyrosine and lipoic acid with water phase components, and heating to 75 deg.C; mixing oilSlowly adding the phase components into the water phase components, emulsifying, cooling to 40 deg.C, adding vitamin B6 and essence, and stirring to obtain the final product.
6. The coenzyme Q according to claim 110The application of the composition and melatonin in preparing an external massage preparation with the effects of helping sleep and beautifying skin is characterized in that the preparation method of the sleep-helping massage oil comprises the following steps:
(1) the raw materials comprise: coenzyme Q100.1-8.0 g of melatonin, 1.0-5.0 g of tyrosine, 0.1-1.0 g of dipotassium glycyrrhizinate, 60.1-1.0 g of vitamin B, 0.01-0.05 g of lipoic acid, 30-35 g of almond oil, 40-50 g of liquid paraffin and 2-3 g of glycerol; 2-3 g of propylene glycol; 0.5-1 g of azone and a proper amount of essence;
(2) the preparation method comprises the following steps: slowly heating all the materials except essence under stirring until all the materials are dissolved, and adding essence when the temperature of the materials is reduced to 45 ℃.
7. The coenzyme Q according to claim 110The application of the melatonin composition in preparing an external massage preparation with the functions of helping sleep and beautifying skin is characterized in that the preparation method of the massage oil for helping sleep and beautifying skin comprises the following steps:
(1) the raw materials comprise: coenzyme Q100.1-8.0 g of melatonin, 1.0-5.0 g of tyrosine, 0.1-1.0 g of dipotassium glycyrrhizinate, 60.1-1.0 g of vitamin B, 0.01-0.05 g of lipoic acid, 40-45 g of isopropyl myristate, 40-45 g of caprylic/capric triglyceride, 8-10 g of silicone oil and 2-3 g of glycerol; 2-3 g of propylene glycol; 0.5-1 g of azone and a proper amount of essence;
(2) the preparation method comprises the following steps: slowly heating all the materials except essence under stirring until all the materials are dissolved, and adding essence when the temperature of the materials is reduced to 45 ℃.
8. The coenzyme Q according to claim 110Application of melatonin composition in preparing external massage preparation with effects of improving sleep and beautifying skinCharacterized in that the optimal formula of the massage milk is as follows: coenzyme Q100.5 g, 3.0g of melatonin, 3.0g of tyrosine, 0.3 g of dipotassium glycyrrhizinate, 0.5 g of menthol, 12 g of almond oil, 60.3 g of vitamin B and 10g of glycerol; 3.0g of azone, 0.5 g of lavender essential oil, 8.0 g of emulsifier, 2.0 g of ethanol and the balance of distilled water to make up to 100 g.
CN201911038985.6A 2019-10-29 2019-10-29 Coenzyme Q10Sleep-aiding skin-beautifying massage emulsion Pending CN110876691A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911038985.6A CN110876691A (en) 2019-10-29 2019-10-29 Coenzyme Q10Sleep-aiding skin-beautifying massage emulsion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911038985.6A CN110876691A (en) 2019-10-29 2019-10-29 Coenzyme Q10Sleep-aiding skin-beautifying massage emulsion

Publications (1)

Publication Number Publication Date
CN110876691A true CN110876691A (en) 2020-03-13

Family

ID=69728459

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911038985.6A Pending CN110876691A (en) 2019-10-29 2019-10-29 Coenzyme Q10Sleep-aiding skin-beautifying massage emulsion

Country Status (1)

Country Link
CN (1) CN110876691A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070196348A1 (en) * 2006-02-23 2007-08-23 Gardiner Paul T Compositions and methods for the induction and maintenance of quality sleep
US20110200575A1 (en) * 2005-05-31 2011-08-18 Naidu Lp Metallo-lactoferrin-coenzyme compositions to improve sleep patterns
CN105456049A (en) * 2015-11-17 2016-04-06 广东医学院 Coenzyme Q10 massage balm with functions of diminishing inflammation, relieving pain and protecting skin
CN106822101A (en) * 2017-02-20 2017-06-13 刘卫 A kind of epiphysin nano-composition and its preparation method and application

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110200575A1 (en) * 2005-05-31 2011-08-18 Naidu Lp Metallo-lactoferrin-coenzyme compositions to improve sleep patterns
US20070196348A1 (en) * 2006-02-23 2007-08-23 Gardiner Paul T Compositions and methods for the induction and maintenance of quality sleep
CN105456049A (en) * 2015-11-17 2016-04-06 广东医学院 Coenzyme Q10 massage balm with functions of diminishing inflammation, relieving pain and protecting skin
CN106822101A (en) * 2017-02-20 2017-06-13 刘卫 A kind of epiphysin nano-composition and its preparation method and application

Similar Documents

Publication Publication Date Title
JP2003334032A (en) Health supplement food having ameliorating action for somnipathy
CN101829043B (en) Traditional Chinese medicine facial mask for improving sleep quality and preparation method thereof
CN104800430A (en) Essential oil for improving depth of sleep
CN103099866B (en) Traditional Chinese medicine composition for treating anxiety and insomnia and preparation method thereof
Shibamoto et al. Aroma therapy in anti-aging medicine
UA87262C2 (en) Method for treating primary insomnia
US20240189382A1 (en) Formula for inhibiting aging regeneration repair
US20230145635A1 (en) Treatment of menstrual cycle-induced symptoms
Williams The new biology of sleep
CN110876691A (en) Coenzyme Q10Sleep-aiding skin-beautifying massage emulsion
KR101971574B1 (en) Cosmetic composition for improving sleep disorder or maintaining deep sleep comprising withania somnifera, morus australis and pure tea extracts
JP2022507646A (en) Uses of braiaconitine A
CN102698091B (en) Traditional Chinese medicine oral liquid for relieving neurasthenia and preparation method
JP2004524344A (en) Use of melatonin in the manufacture of a medicament for the treatment of attention deficit hyperactivity disorder
CN110898081A (en) External massage preparation with functions of helping sleep and beautifying skin
CN109464451B (en) Medicine for treating neurasthenia and preparation method thereof
US10959450B2 (en) Food composition for relieving symptoms of allergic and autoimmune diseases
CN113209051A (en) Hot compress patch for treating insomnia and preparation process and use method thereof
CN115350260B (en) Daily care biological agent with sleep-aiding function for skin and preparation method thereof
JP2010229102A (en) Sleep disorder-improving agent
CN102872200A (en) Externally-applied medicine for treating alopecia areata
CN110269926A (en) Middle benefit gas, which is relaxed, warms up composition and its preparation method and application
KR101273027B1 (en) Composition for inhibiting sebum secretion and anti-obesity comprising kaempferol
CN111135304A (en) Combined medicine for treating chronic, intractable or primary insomnia and its use
JP6800404B2 (en) Autonomic regulator

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200313

WD01 Invention patent application deemed withdrawn after publication